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Abstract
Calmodulin kinase II (CaMKII) mediates critical signaling pathways responsible for divergent functions in the heart including
calcium cycling, hypertrophy and apoptosis. Dysfunction in the CaMKII signaling pathway occurs in heart disease and is
associated with increased susceptibility to life-threatening arrhythmia. Furthermore, CaMKII inhibition prevents cardiac
arrhythmia and improves heart function following myocardial infarction. Recently, a novel mechanism for oxidative CaMKII
activation was discovered in the heart. Here, we provide the first report of CaMKII oxidation state in a well-validated, large-
animal model of heart disease. Specifically, we observe increased levels of oxidized CaMKII in the infarct border zone (BZ).
These unexpected new data identify an alternative activation pathway for CaMKII in common cardiovascular disease. To
study the role of oxidation-dependent CaMKII activation in creating a pro-arrhythmia substrate following myocardial
infarction, we developed a new mathematical model of CaMKII activity including both oxidative and autophosphorylation
activation pathways. Computer simulations using a multicellular mathematical model of the cardiac fiber demonstrate that
enhanced CaMKII activity in the infarct BZ, due primarily to increased oxidation, is associated with reduced conduction
velocity, increased effective refractory period, and increased susceptibility to formation of conduction block at the BZ
margin, a prerequisite for reentry. Furthermore, our model predicts that CaMKII inhibition improves conduction and reduces
refractoriness in the BZ, thereby reducing vulnerability to conduction block and reentry. These results identify a novel
oxidation-dependent pathway for CaMKII activation in the infarct BZ that may be an effective therapeutic target for
improving conduction and reducing heterogeneity in the infarcted heart.
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Introduction
Calmodulin kinase II (CaMKII) mediates diverse roles in the
heart, including excitation-contraction coupling, sinus node auto-
maticity, apoptosis, hypertrophy, and gene transcription [1,2].
Mounting experimental evidence demonstrates an important role
forCaMKII inheart diseaseand arrhythmias. Specifically,CaMKII
overexpression occurs in human heart failure [3] and transgenic
mice overexpressing CaMKII develop dilated cardiomyopathy
[4,5]. Conversely, transgenic inhibition of CaMKII prevents
structural remodeling and improves heart function following
myocardial infarction (MI) [6] while knockout mice lacking the
predominant cardiac CaMKII isoform (CaMKIId) are resistant to
development of pressure overload-induced hypertrophy and/or
heart failure [7,8]. Finally, CaMKII inhibition prevents arrhythmias
in several different mouse models of heart disease [9,10].
CaMKII is activated by binding of Ca
2+/calmodulin and may
undergo inter-subunit autophosphorylation that allows the kinase to
retain activity even upon dissociation of Ca
2+/calmodulin (auton-
omy) [11]. Recently, a novel CaMKII activation pathway was
identified where oxidation at specific methionine residues in the
CaMKII regulatory subunit results in persistent activity indepen-
dent of autophosphorylation [12]. While oxidative-dependent
CaMKII activation has been shown to mediate apoptosis in
response to chronic AngII treatment in the mouse [12] as well as
arrhythmogenic afterdepolarizations in isolated cardiomyocytes
treatedwithhydrogen peroxide[13],nothing isknownaboutitsrole
in large animal models of heart disease. Considering that levels of
reactive oxygen species (ROS) such as H2O2 and superoxide are
elevated following myocardial infarction [14], we hypothesized that
oxidation of CaMKII represents an important pathway for
CaMKII activation in the infarct border zone (BZ) that may
provide a mechanistic link betweenincreased ROS production, Na
+
channel remodeling and conduction slowing following MI.
In this study, we describe a dramatic increase in levels of
oxidized CaMKII in a well-validated large animal model of
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oxidized CaMKII in regulating refractoriness and conduction in
the infarct BZ, we develop a novel mathematical model of
CaMKII activity that includes oxidation and autophosphorylation
activation pathways. Our computer simulations show that
enhanced CaMKII activity in the BZ, due primarily to increased
oxidation, leads to slowed conduction, prolonged refractory
periods and increased vulnerability to conduction block at the
BZ margin (a prerequisite for reentry initiation). Our results
identify oxidation-dependent CaMKII activation as a potential
link between oxidative stress and electrical remodeling after
myocardial infarction. Furthermore, our findings support CaMKII
inhibition as a potential therapy for reducing susceptibility to
ventricular tachycardia by improving conduction and reducing
refractory gradients in the infarcted heart. Finally, it is important
to note the oxidative activation of CaMKII allows for independent
regulation of the kinase by a host of unique upstream activators
and signaling partners (e.g. oxidases/reductases) with great
potential relevance to human disease. As details emerge regarding
regulation of the kinase by this newly identified pathway, they may
be incorporated into our model to study electrophysiological
consequences of CaMKII activation via this independent signaling
pathway.
Materials and Methods
Experimental model of myocardial infarction and
immunoblotting. Myocardial infarction (MI) was produced
by total coronary artery occlusion, as described previously [22]. A
cardiectomy was performed five days after surgery and thin tissue
slices from visible epicardial BZ and from a remote area away
from the infarct (left ventricular base) were flash frozen for
immunoblot analysis. Ventricular lysates were prepared for
immunoblot analysis as described [21]. Equal quantities of
protein were analyzed by SDS-PAGE (3–8% Tris acetate gels)
under non-reducing conditions [12]. Immunoblotting was
performed using a validated antiserum to oxidized CaMKII
[12]. Slight differences in protein loading were corrected using an
internal control standard (rabbit polyclonal antibody to actin
(Santa Cruz)).
Animal information. This investigation used adult mongrel
dogs (12 to 15 kg, 2 to 3 years old) and conforms to the Guide for
the Care and Use of Laboratory Animals published by the
National Institutes of Health (Pub. No. 85-23,1996).
Fiber model. A multicellular fiber comprised of 200 cells in a
serial arrangement was used to simulate action potential (AP)
propagation through normal and border zone tissue as described
previously [23]. Briefly, Equation 1 describing axial current flow
along the theoretical fiber was discretized and solved numerically
by the Crank-Nicholson implicit method:
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where Iax is the axial current, a is the fiber radius (0.0011 cm), Ri is
the axial resistance per unit length (V.cm, composed of Rmyo
(150 Vcm) and Rg (1.5 Vcm
2)), Cm is the membrane capacitance
(1 mF/cm
2), and Iion is the transmembrane current density. A
discretization element of Dx=0.01 cm corresponding to one cell
length was used in all simulations. An adaptive time step (Dt) was
implemented that solves for transmembrane currents and Vm along
the fiber with Dt=5ms during AP wavefront propagation,
Dt=10ms during repolarization, and Dt=50ms during diastole.
Solutions using the adaptive timestep were verified to be within
1% of those using a constant Dt=5ms.
Transmembrane currents and ion concentration changes at
each cell in the fiber are described by the Hund-Rudy dynamic
(HRd) model of the canine epicardial myocyte [20,24]. Modifi-
cations to the HRd equations to account for experimentally
measured remodeling changes to several major ion channels in the
infarct border zone [20] were used to represent each cell in the BZ
fiber model. Equations differing from the original publications and
variable definitions may be found in supplementary information
(Text S1 and Table S1).
Pacing protocol. The fiberwas paced atoneendtosteady state
using a conservative current stimulus [25] (cycle length =500 ms,
stimulus amplitude =2450 mA/mF, stimulus duration =0.5 ms).
The steady-state values for all state variables were used as initial
conditions (Table S2) for subsequent simulations.
Statistics. When appropriate, differences between groups
were analyzed with ANOVA and least squares difference post-hoc
test. A value of p,0.05 was considered statistically significant.
Values are expressed as mean 6 SD.
Results
CaMKII is oxidized in the infarct border zone
Based on the recent discovery of a novel oxidation-dependent
pathway for CaMKII activation [12], immunoblot analysis was
first performed in a well-validated large animal model of
arrhythmias [15–22] to determine whether oxidization of CaMKII
occurs in the infarct BZ five days post-occlusion (Figure 1).
Interestingly, levels of oxidized CaMKII were over eight-fold
greater in the five-day BZ compared to normal (non-infarcted)
(p,0.01), but were unchanged in remote regions of the same
hearts (Figure 1, p=NS vs. normal). These data together with our
previous findings that CaMKII autophosphorylation is significant-
ly increased in the five-day infarct BZ [20] indicate that CaMKII
activity is enhanced in the infarct BZ.
Author Summary
Calmodulin kinase II (CaMKII) is a multifunctional serine/
threonine kinase that regulates diverse functions in heart.
Recently, a novel pathway for CaMKII activation was
discovered where oxidation of the kinase at specific
methionine residues produces persistent activity. This
alternative oxidation-dependent pathway has important
implications for heart disease where oxidative stress is
increased (e.g., heart failure and following myocardial
infarction). We hypothesized that myocardial infarction
caused by occlusion of a coronary artery would increase
levels of oxidized CaMKII. Moreover, we hypothesized that
oxidative CaMKII activation represents an important
mechanistic link between increased oxidative stress and
life-threatening heart rhythm disturbances (arrhythmias) in
heart disease. We report a dramatic increase in levels of
oxidized CaMKII following myocardial infarction in the
canine. Based on these experimental data, we developed a
novel mathematical model of CaMKII activity to study the
role of oxidation-dependent CaMKII activation in regulat-
ing cardiac cell excitability. Our findings identify a novel
role for oxidation-dependent CaMKII activation following
myocardial infarction and provide a mechanistic link
between oxidative stress and lethal cardiac arrhythmias
in heart disease.
Oxidized CaMKII Regulates Conduction
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propagation
To determine whether enhanced CaMKII activity, due in part
to oxidation (Figure 1), regulates conduction in the infarct BZ, we
revised our model of the canine ventricular action potential
[20,24] to include a new model of CaMKII activity based on the
simplified scheme proposed by Dupont et al [26–28] (Figure 2).
Importantly, our model includes an oxidized active state in
addition to a Ca
2+/CaM bound active state and an autopho-
sphorylated active state. Inclusion of an additional autonomous
active state (Ca
2+/CaM dissociates from phosphorylated subunit)
was found to have no impact on model behavior (state occupancy
,0.001%, not shown) and was therefore not included in the final
model. Consistent with experimental observations [12], Ca
2+/
CaM must bind to a subunit before oxidation may occur (no direct
transition from inactive to oxidized active state). Rate constants for
state transitions were taken from the literature or chosen to fit
experimental data (Table S3, Figure 2B–D). Model equations are
provided in supplementary information (Text S1). Our experi-
mental data demonstrate a significant increase in both oxidized
(Figure 1) and autophosphorylated CaMKII [20] in the infarct BZ.
Even though autophosphorylation and oxidation occur through
distinct pathways, the model assumes that the same subunit may
be both oxidized and autophosphorylated. Furthermore, consis-
tent with previous work [26–28], the model assumes that any
active subunit (including oxidized) may autophosphorylate another
Ca
2+/CaM bound subunit. Thus, the model predicts a secondary
increase in the fraction of autophosphorylated CaMKII subunits
with an increase in oxidized subunits due to oxidative stress
(Figure 2E). Currently, the upstream pathways responsible for
increased CaMKII autophosphorylation are unknown. However,
our model predicts that oxidative stress may account for the
increase in both oxidized and autophosphorylated subunits
measured in the infarct BZ (Figure 2E). Thus, for the purpose of
this study, we assume that the primary defect responsible for
activated CaMKII in the BZ is oxidative stress.
While absolute measures of H2O2 levels are limited (likely less
than 0.25 mM at baseline [29,30]), an increase in ROS levels from
10- to 100-fold have been reported following ischemia-reperfusion
[31–33]. Furthermore, ROS levels of 10 mM in vitro have been
shown to recapitulate the level of oxidative stress observed in vivo in
the BZ [34]. Unless otherwise stated, we assume [ROS] =1.0 mM
in the BZ, likely a conservative estimate. However, based on the
fact that the exact level of ROS is unknown in the BZ and is likely
to be highly heterogeneous, we also explore a range of ROS levels
from 0 to 10 mM. Note that for [ROS] =1 mM, the fraction of
autophosphorylated subunits in the BZ is much lower than the
fraction of oxidized subunits (0.11 for autophosphorylation
compared to 0.75 for oxidation, Figure 2E), indicating that
oxidation rather than autophosphorylation is the primary
determinant of increased CaMKII activity in the BZ model.
Importantly, our model of the BZ myocyte also accounts for
observed remodeling changes to the density and/or kinetics of
several ion channels, including the L-type Ca
2+ current, transient
outward K
+ current, and Na
+ current [20]. Specifically for the Na
+
current, changes to kinetics and peak current have been observed
[22]. Since CaMKII has been shown to alter Na
+ channel kinetics
but not peak current, our model assumes that the reduction in total
Na
+ channel density occurs through a CaMKII-independent
pathway [20]. NZ (control) and BZ cell models are incorporated
into one-dimensional fibers to study conduction (Figure 3).
CaMKII regulates INa inactivation in border zone
INa inactivation and recovery from inactivation were first
determined in the NZ and BZ fiber after pacing to steady state
(Figure 4). INa recovery from inactivation was determined by
applying a premature stimulus (S2) at a varying S1S2 interval and
plotting channel availability (calculated as product of inactivation
gates, h*j) vs. recovery interval (S1S2 interval - APD90). INa steady-
state inactivation is shifted to more hyperpolarized potentials
(Figure 4A) and recovery from inactivation is slower (Figure 4C) in
the BZ fiber compared to NZ, consistent with our single cell
simulations [20] and experimental measurements [22]. CaMKII
inhibition (CaMKII activity held constant at zero) shifts INa steady
state inactivation to more depolarized potentials (Figure 4A) and
accelerates recovery from inactivation in the BZ fiber (Figure 4C)
but has little effect in NZ (steady-state inactivation and recovery
curves superimpose curves from BZ+CaMKII inhibition model,
not shown). Thus differences in INa inactivation between NZ and
BZ observed under control conditions are largely eliminated upon
CaMKII inhibition (Figure 4).
CaMKII regulates conduction in border zone
Based on the effects of CaMKII on INa availability, we
hypothesized that enhanced CaMKII activity would promote
slow conduction in the BZ. While resting transmembrane potential
is comparable between isolated BZ and NZ myocytes [19],
Figure 1. Increased levels of oxidized CaMKII following
myocardial infarction. (A) Representative immunoblots and (B)
densitometric measurements (normalized to actin and expressed
relative to normal levels) of oxidized CaMKII from remote and BZ
regions of normal and infarcted hearts. Error bars designate standard
deviation (*p,0.01 compared to normal BZ or remote, n=4).
doi:10.1371/journal.pcbi.1000583.g001
Oxidized CaMKII Regulates Conduction
PLoS Computational Biology | www.ploscompbiol.org 3 December 2009 | Volume 5 | Issue 12 | e1000583membrane depolarization is observed in multicellular BZ
preparations [35,36]. Therefore, we measured conduction velocity
in NZ and BZ fibers over a range of end diastolic potentials
(Vm,dia, 286 to 263 mV), by increasing [K
+]o incrementally from
5.4 to 13 mM. Conduction velocity was measured across the
central 100 cells (Figure 5). Conduction was dramatically slower at
every Vm,dia in the BZ compared to NZ (65–100% slower)
(Figure 5A). Furthermore, while successful conduction was
observed in the NZ for potentials up to 264 mV, conduction
block occurred in the BZ for Vm,dia .272 mV. In fact,
conduction velocity is steeply dependent on the concentration of
ROS in the BZ over a range of concentrations from about
0.01 mMt o1mM (Figure S1). To determine the role of oxidation-
dependent CaMKII activity in conduction slowing in the BZ, we
measured conduction velocity in the BZ model resistant to
CaMKII oxidation (CaMKIIox =0). Making CaMKII resistant
to oxidation increased conduction velocity at all Vm,dia in the BZ
with a greater effect at more depolarized Vm,dia (Figure 5A).
Moreover, successful conduction was restored in the BZ for Vm,dia
up to 268 mV (compared to 264 mV in the control). In contrast,
the BZ model resistant to CaMKII autophosphorylation showed
very little improvement in conduction (Figure S2). Furthermore,
inhibiting total CaMKII activity showed a similar improvement in
conduction as the oxidation-resistant model (Figure 5B), indicating
that oxidation is the primary determinant of enhanced kinase
activity in our BZ model. To verify that CaMKII-dependent
effects on conduction were mediated by regulation of INa kinetics,
we also calculated conduction velocity in the BZ model with INa
resistant to CaMKII phosphorylation. As expected, this model
showed a similar improvement in conduction as the oxidation-
resistant model (Figure 5B), indicating that enhanced CaMKII
activity regulates conduction by altering INa kinetics. In summary,
enhanced CaMKII activity contributes to reduced conduction
velocity in the BZ fiber, even promoting conduction block in the
setting of depolarized transmembrane potential.
Remodeling in BZ tissue involves not only changes to ion
channel properties and rest potential, but also intracellular
communication [37,38]. In order to address whether cellular
uncoupling affects the role of oxidized CaMKII in regulating
conduction, we determined conduction velocity in the fiber over a
range of gap junction resistances (Figure 5C). Increasing gap
junctional resistance (Rg) from 1.5 to 60 Vcm
2 produced a similar
Figure 2. Mathematical model of CaMKII activity. (A) State diagram for CaMKII including activation by Ca
2+/CaM (B), oxidation (Ox), and
autophosphorylation (P). Rate constants are provided in supplementary information (Text S1 and Table S3). (B) Simulated dose-dependent activation
of CaMKII by H2O2 compared to experiment [12]. Ca
2+/CaM =1 mM and autophosphorylation rate =0 in simulations corresponding to the following
experimental conditions: 200 mMC a
2+,1mM CaM in the absence of ATP (to prevent autophosphorylation). Simulated CaM dependence of (C) CaMKII
activity and (D) autophosphorylation compared to experiment [50]. Saturating conditions for Ca
2+ (Ca
2+=0.5 mM) are used in experiment and
simulation to allow for control of [Ca
2+/CaM] by varying [CaM]. (E) Simulated levels of CaMKII oxidation and autophosphorylation in the BZ model for
different levels of oxidative stress (model paced to steady-state at cycle length of 500 ms).
doi:10.1371/journal.pcbi.1000583.g002
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90% decrease, respectively). Successful conduction occurred in the
NZ fiber for Rg up to 300 Vcm
2, while conduction block was
observed in the BZ fiber for Rg.76 Vcm
2. Eliminating oxidation-
dependent CaMKII activity increased conduction velocity in the
BZ fiber at all Rg and restored conduction for Rg up to 150 Vcm
2
(Figure 5C), indicating that CaMKII regulates conduction even in
the setting of gap junction uncoupling.
CaMKII regulates effective refractory period in border
zone
Effective refractory period (ERP) of the action potential is
dramatically prolonged in BZ compared to NZ, despite compa-
rable action potential durations [18,19,35]. Moreover, large
gradients in refractoriness at the BZ margin have been associated
with conduction block and the initiation of reentrant arrhythmias
[15,17,18]. Based on these data and the ability of CaMKII to
regulate INa recovery from inactivation (Figure 4C), we hypoth-
esized that enhanced CaMKII activity would contribute to
prolonged refractoriness in the BZ. To test our hypothesis, ERP
was determined in NZ and BZ fibers by applying a premature (S2)
stimulus during the repolarization phase of the action potential at
cell 1 (site of S1 stimulus). The S1S2 interval was increased until a
second propagating wave was generated in the wake of the final S1
stimulated AP (Figure 6). ERP is defined as the largest S1S2
interval that fails to generate a propagating excitation wave and is
a function of both action potential duration (APD) and
postrepolarization refractoriness. Consistent with experiment
[18,19,35], ERP is much greater in the BZ model (213 ms
compared to 181 in the NZ) (Figure 6). Small differences in APD
(173 ms and 187 ms in NZ and BZ, respectively) account for only
a portion of this difference in ERP. Rather the primary
determinant of prolonged ERP in the BZ is increased postrepolar-
ization refractoriness due to the much slower time course of
recovery from inactivation of INa (Figure 4C). Making CaMKII
resistant to oxidative activation reduces ERP to 207 ms in the BZ
model despite a slight prolongation of APD (Figure 6C) by
eliminating differences in postrepolarization refractoriness (mea-
sured as ERP – APD, Figure 6D). Likewise, total CaMKII
inhibition and making INa resistant to CaMKII phosphorylation
reduce ERP by normalizing postrepolarization refractoriness
(Figure 6D). These results suggest that oxidation-dependent
CaMKII activation contributes to large gradients of refractoriness,
particularly at the margins of the infarct BZ, by regulating INa
kinetics.
CaMKII increases vulnerability to conduction block
Electrophysiological mapping during programmed stimulation
to induce ventricular tachycardia has revealed that premature
excitation block occurs in areas of large refractory gradients at the
BZ margin [18]. Our findings that enhanced CaMKII activity
substantially increases ERP in the BZ led us to hypothesize that
CaMKII promotes formation of conduction block at the transition
between normal and border zone tissue by introducing large
refractory gradients. To test our hypothesis, we used a heteroge-
neous fiber comprised of coupled NZ (cells 1–75) and BZ (cells
126–200) cells with a central transitional region (cells 76–125)
across which BZ parameters were linearly scaled. The size of the
transitional region corresponds to the approximate width of the
outer common pathway (about 5.0 mm [15]) (Figure 7A). The
fiber was paced to steady state at cell 1 and a premature S2
stimulus was applied at the same cell. The S1S2 pacing interval
was varied to determine the critical range of S1S2 intervals
(vulnerable window, VW) that resulted in conduction block at the
transition from the NZ into the BZ region. S1S2 intervals from
181 to 197 ms (VW=18 ms) resulted in an action potential that
Figure 3. Mathematical model of cardiac action potential and electrical conduction. (A) Hund-Rudy dynamic (HRd) canine ventricular
epicardial cell model. Symbols are defined in text and in Table S1. (B) One-dimensional fiber model comprised of individual cells electrically coupled
through gap junctions. A current stimulus is applied at the end of the fiber (cell 1) and the excitation wavefront propagates down the fiber. (C)
Simulated action potentials from every 20
th cell in the control (top) and border zone (bottom) fibers.
doi:10.1371/journal.pcbi.1000583.g003
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transition into the BZ region (Figure 7A). S1S2 pacing intervals
shorter than this critical range failed to propagate even through
the NZ region while S1S2 intervals greater than this range
successfully propagated through the entire fiber (Figure 7B). Vm
and INa availability (h*j) spatial profiles as the wavefront reaches
the BZ margin indicate that INa availability is a critical
Figure 4. CaMKII regulates INa in the infarct border zone. (A)
Steady-state INa inactivation curves in NZ and BZ models (pulse protocol
shown in inset). Inhibition of the CaMKII pathway (CaMKII activity held
constant at zero) eliminates differences between NZ and BZ INa steady-
state inactivation. (B) Simulated Na
+ currents in control (top) and border
zone (bottom) models during application of a premature stimulus to cell
1 at varying S1S2 interval to determine recovery from inactivation. (C)
INa availability (h*j) in control and border zone models with and without
CaMKII inhibition. INa recovery is dramatically slower in the border zone
fiber compared to control. CaMKII inhibition in the BZ accelerates
recovery from inactivation to a rate similar to NZ (recovery curve for NZ
model + CaMKII inhibition superimposes curve for BZ model + CaMKII
inhibition, not shown).
doi:10.1371/journal.pcbi.1000583.g004
Figure 5. CaMKII regulates conduction in the infarct border
zone. (A) Conduction velocity vs. end diastolic potential (Vm,dia)i n
normal and border zone fibers. [K
+]o is increased incrementally from
5 . 4 m Mt o1 3 m Mt od e p o l a r i z eV m,dia from 287 to 263 mV.
Elimination of oxidation-dependent CaMKII activation (oxidation-
resistant CaMKII) increases conduction velocity at all Vm,dia and extends
the range of Vm,dia over which successful conduction occurs in the
border zone fiber. (B) Total CaMKII inhibition and eliminating CaMKII-
dependent effects on INa have a similar effect on conduction velocity as
making CaMKII resistant to oxidation. (C) Conduction velocity vs. gap
junction resistance (Rg) in NZ and BZ fibers ([K
+]o =8.0 mM). Eliminating
oxidation-dependent CaMKII activation improves conduction in the BZ
fiber even at very high degrees of cell uncoupling (Rg up to 150 Vcm
2).
doi:10.1371/journal.pcbi.1000583.g005
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BZ margin (Figure 7C).
Figure 8 shows VW in the heterogeneous fiber as a function of
Vm,dia in the BZ region ([K
+]o was scaled linearly across the
transition region as with other BZ parameters). VW shows a
monophasic increase as Vm,dia is depolarized from 285 mV to
272 mV. Vm,dia greater than 272 mV results in transient block at
the BZ margin even at the basic cycle length of 500 ms. Making
CaMKII resistant to oxidative activation greatly reduces VW at all
Vm,dia (Figure 8A). Furthermore, transient block is not observed at
the basic cycle length until Vm,dia is depolarized above 268 mV.
Total CaMKII inhibition and making INa resistant to CaMKII
phosphorylation also effectively prevented formation of block at
the BZ margin (VW less than 1 ms for Vm,dia up to 272 mV and
274 mV, respectively, not shown).
While these data show that oxidation-dependent CaMKII
activation increases the vulnerability to conduction block at the BZ
margin, a prerequisite for initiation of reentrant arrhythmias, it is
important to note that CaMKII-independent remodeling of ion
channels (notably INa) also likely play an important role. To
address the role of CaMKII-independent remodeling in conduc-
tion block, we measured VW in the heterogeneous fiber with
normal INa conductance throughout. Eliminating differences in
INa conductance successfully reduced vulnerability to transient
conduction block across a wide range of Vm,dia (Figure 8A),
indicating that both CaMKII-dependent (altered kinetics) and
CaMKII-independent (reduced channel conductance) effects on
INa increase the vulnerability to conduction block and reentrant
arrhythmias at the BZ margin. Interestingly, eliminating either
CaMKII-dependent (oxidation-resistant CaMKII) or CaMKII-
independent (normal GNa) heterogeneities in the fiber resulted in a
similar increase in the effective INa availability (GNa   h   j) in the
transition region (Figure 8B).
We next determined whether cellular uncoupling in the BZ
region would alter the role of CaMKII-dependent or CaMKII-
independent INa changes in formation of conduction block at the
BZ margin (Figure 8C). Increasing Rg in the BZ region (Rg scaled
linearly across the transition region as with other BZ parameters)
had very little effect on VW for a moderate degree of uncoupling
(Rg up to 38 Vcm
2). However, VW increased sharply for Rg.38
Vcm
2 until block occurred at the BZ margin even at the basic
cycle length (Rg.60 Vcm
2). Eliminating oxidation-dependent
CaMKII activation or normalizing INa conductance reduced VW
at all Rg (VW=0 ms for Rg up to 120 Vcm
2 and 150 Vcm
2,
respectively) indicating that CaMKII-dependent and CaMKII-
independent effects on INa regulate VW even in the presence of
cellular uncoupling.
Discussion
Our data provide the first evidence for oxidation of CaMKII as
an important component of the remodeling process following MI.
Furthermore, our simulation results provide the following insight
into regulation of CaMKII signaling by this novel oxidative
pathway: 1) Significant oxidative activation of the kianse occurs
under pathophysiological conditions; 2) Oxidative stress may
activate the kinase not only through direct oxidation but also
through a secondary increase in autophosphorylation; and 3)
Changes in Na
+ channel kinetics due to oxidative CaMKII
activation are sufficient to impact conduction in the BZ.
Conduction in the canine infarct border zone is highly irregular
with areas of very slow and discontinuous conduction during sinus
rhythm [17]. During programmed stimulation, lines of conduction
block often form transverse to the fiber axis leading to initiation of
Figure 6. CaMKII regulates effective refractory period in the
infarct border zone. A premature stimulus is applied to cell 1 at
varying S1S2 intervals to determine the effective refractory period in (A)
NZ, (B) BZ, and (C) BZ with oxidation-resistant CaMKII. Simulated action
potentials are shown from cells 1, 20, 40, 60, and 80 along the fiber for
the shortest S1S2 interval that generates a successfully propagating
action potential. While ERP is longer in the BZ than in NZ (213 ms and
181 ms, respectively), elimination of oxidation-dependent CaMKII
activation reduces these differences. (D) Postrepolarization refractori-
ness (ERP-APD90) in NZ, BZ, BZ with oxidation-resistant CaMKII, BZ with
total CaMKII inhibition, and BZ with CaMKII-resistant INa.
doi:10.1371/journal.pcbi.1000583.g006
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mechanisms responsible for conduction block and reentry in the
BZ are unknown although remodeling changes in tissue
refractoriness and electrical coupling most likely play important
roles [15–18]. At the cellular level, it is clear that Na
+ channel
dysfunction contributes to reduced action potential upstroke and
action potential amplitude in myocytes isolated from the infarct
border zone [19,22]. Previous modeling studies have shown that
decreased Na
+ channel availability contributes to prolonged
refractoriness in BZ cells despite AP duration comparable to NZ
[39] and that slowing of Na
+ channel recovery from inactivation or
reducing Na
+ channel conductance increases the vulnerable
period for unidirectional block in cardiac tissue [40]. Our
simulations demonstrate that CaMKII may regulate both
conduction velocity and refractoriness in the BZ through its
effects on voltage-gated Na
+ channel kinetics. Furthermore, by
introducing gradients in INa availability and refractoriness,
CaMKII activation, due in part to oxidation, increases vulnera-
bility to conduction block at the BZ margin, a prerequisite for
reentrant excitation. Moreover, our simulations suggest that
CaMKII inhibition improves conduction (particularly in depolar-
ized tissue) and reduces ERP in the BZ, thereby reducing the risk
for conduction block and reentrant excitation. These results are
significant in light of experimental mapping studies showing
premature excitation block in areas of large gradients in
refractoriness [18]. While the current study focuses on conduction
defects in the BZ, it is important to note that CaMKII activation is
also expected to regulate intracellular Ca
2+ cycling that itself may
promote arrhythmias [2].
Our findings regarding the effects of CaMKII on conduction
are consistent with experimental studies in mice that over-express
CaMKIId. Specifically, consistent with our simulations, CaMKIId
over-expression results in prolonged QRS intervals (marker of
slowed intraventricular conduction) and increased arrhythmia
susceptibility [41]. In contrast, our finding that CaMKII acts to
increase post-repolarization refractoriness and therefore ERP in
the BZ does not agree with shorter refractory periods in CaMKIId
mice [41]. While the nature of this discrepancy is unclear, it is
difficult to reconcile the reported effects of CaMKII on Na
+
channel recovery (slowing) with the measured effects on refracto-
riness in transgenic mice. It is possible that the decrease in ERP
measured in transgenic mice is due to secondary effects of chronic
CaMKII over-expression rather than acute signaling effects.
Regardless, further studies are needed to define the role of
CaMKII in regulating refractoriness in the heart.
Clearly, many factors besides remodeling of voltage-gated Na
+
channels influence conduction in the infarct BZ. Specifically,
alterations in cell-to-cell coupling due to gap junction remodeling
Figure 7. Role of CaMKII in formation of conduction block at the border zone margin. (A) Conduction block in a one-dimensional fiber
comprised of NZ (cells 1–75), BZ (cells 126–200), and transitional (cells 76–125) regions. A premature S2 stimulus is applied at cell 1 to induce
conduction block at the BZ margin (S1S2 =190 ms). (B) Application of S2 at a coupling interval greater the vulnerable window (S1S2 =500 ms)
results in successful conduction through the entire fiber. (C) Vm and INa availability (h*j) along the fiber as the wavefront reaches the BZ margin for a
premature stimulus that blocks (S1S2 =181 ms, black lines) or propagates successfully through the entire fiber (S1S2 =198 ms, red lines).
doi:10.1371/journal.pcbi.1000583.g007
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conduction. In fact, studies have shown a close correlation
between location of the central common pathway of the reentrant
circuit and connexin43 redistribution suggesting that gap junction
remodeling is required for maintenance of reentrant excitation
[37,38]. Furthermore, preferential uncoupling along the transverse
fiber axis is thought to increase the degree of anisotropy in the BZ
and facilitate initiation and maintenance of reentry. In addition,
remodeling of the extracellular space in the BZ likely interacts with
changes in gap junction coupling to affect conduction [42]. Thus,
cell communication is regulated by a complex set of ion channel
and structural changes in the BZ. Importantly, we find that
CaMKII-dependent changes in INa kinetics regulate conduction in
the BZ independent of the degree of cell coupling. Moreover, we
report that CaMKII inhibition may restore conduction in the BZ
even in the setting of very poor coupling (Rg up to 150 Vcm
2).
Previous studies have shown increased levels of ROS in five-day
infarct BZ regions [34]. Moreover, exposure of cardiac Na
+
channels expressed in HEK cells to ROS recapitulates the
remodeling phenotypes observed in BZ myocytes. Our results
suggest that the newly discovered oxidation-dependent pathway
for CaMKII activation serves as a critical link between oxidative
stress, enhanced CaMKII activity, Na
+ channel dysfunction, and
abnormal conduction in the infarct BZ. Of course, CaMKII is
unlikely to be the only pathway through which oxidative stress
alters cell excitability as oxidation affects many proteins in the
heart, including kinases, transcription factors, ion channels,
pumps, transporters, Ca
2+ handling proteins, and contractile
machinery [43].
While studies from our group and others demonstrate an
important role for activated CaMKII in remodeling following MI,
the upstream signaling pathways responsible for enhanced CaMKII
activity remain to be fully elucidated (Figure 8). In this study, we
assume that oxidative stress is the primary cause of enhanced
CaMKII activity through direct oxidation of the kinase that also
producesa secondaryincrease inthe fractionofautophosphorylated
subunits (Figure 2E). Clearly, CaMKII oxidation downstream of
increased ROS production is one possible pathway for CaMKII
activation in the BZ (Figure 1). However, a number of other
upstreamfactorslikelyplayanimportantroleinregulatingCaMKII
activity following MI. For example, b-adrenergic stimulation,
observed in the setting of myocardial infarction, activates CaMKII
[6] and may also contribute to electrical remodeling after MI.
Another possible mechanism for dysfunction in the CaMKII
signaling pathway involves loss of coordinate regulation by
phosphatases. Recently, it was discovered that miR-1 over-
expression causes CaMKII-dependent hyperphosphorylation of
RyR2 and afterdepolarizations due to reduced expression of the
B56a regulatory subunit of the serine/threonine protein phospha-
tase 2A, PP2A [44]. Previous studies from our group have shown
that B56a binds to, and is targeted by the adapter protein ankyrin-B
in heart [45,46]. Furthermore, B56a expression is reduced in
cardiomyocytes lacking ankyrin-B [45]. More recently, we have
shown that expression levels of ankyrin-B are significantly reduced
inthe BZleading to altered expression and distribution ofankyrin-B
associated membrane proteins including PP2A [21]. Interestingly,
previous modeling studies have shown that loss of local phosphatase
signaling may greatly potentiate levels of autophosphorylated
CaMKII [27]. Therefore, loss of ankyrin-B may provide another
mechanism for abnormal CaMKII signaling in the BZ through
abnormal localization and/or activity of PP2A. Interestingly,
patients with ankyrin mutations show catecholaminergic-induced
afterdepolarizations[47–49] asobservedincellswithreduced B56a.
Future studies are needed to define the upstream signaling
pathway(s) responsible for CaMKII activation, Na
+ channel
remodeling and increased susceptibility to reentrant arrhythmias
after MI.
Figure 8. Vulnerable window for conduction block. (A) Range of
S1S2 intervals that result in conduction block at the BZ margin
(vulnerable window) as a function of end diastolic potential (Vm,dia)i n
the BZ region. Results are shown for the fiber with heterogeneous
properties (control, black line), with oxidation-resistant CaMKII (red line),
and with normal INa conductance throughout (gray line). Eliminating
oxidation-dependent CaMKII activity or heterogeneity in INa conduc-
tance greatly reduces the VW at all Vm,dia. (B) Vm and effective INa
availability (GNa   h   j) along the fiber as the action potential wavefront
reaches the BZ margin for the fiber with heterogeneous properties
(control, black lines), with oxidation-resistant CaMKII (red lines), and with
normal INa conductance throughout (gray lines). [K
+]o=8.0 mM in the
BZ region (and scaled linearly across the transition region). (C)
Vulnerable window as a function of gap junction resistance (Rg)i n
the BZ region for the fiber with heterogeneous properties (control,
black line), with oxidation-resistant CaMKII (red line), and with normal INa
conductance throughout (gray line). Eliminating oxidation-dependent
CaMKII activity or normalizing INa conductance reduces VW at all Rg.
doi:10.1371/journal.pcbi.1000583.g008
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direct oxidation has only recently been discovered. Consequently,
much remains unknown regarding the signaling mechanisms that
regulate this pathway. Analogous to regulation of autophosphoryla-
tionbylocalkinase/phosphataseactivityandlocalconcentrations of
Ca
2+/calmodulin, oxidative activation is likely controlled by a
delicate balance of oxidase/reductase activity, mitochondrial
function and local calcium signaling. Furthermore, degree of
crosstalk between oxidative and autophosphorylation pathways and
their relative importance in response to the complex set of upstream
stressors in heart disease remain to be determined. These details, as
they emerge, may be incorporated into our model to analyze the
functional consequences of upstream signals that converge through
distinct pathways to alter CaMKII activity.
Limitations
While our mathematical model accounts for central aspects of
the newly identified oxidation-dependent pathway for CaMKII
activation, it has important limitations based on the available
experimental data. Many questions remain to be answered
regarding the function of CaMKII oxidation in the normal and
diseased heart. For example, how do oxidation and autopho-
sphorylation of CaMKII interact to control regulation of the
holoenzyme? Do these pathways interact synergistically to activate
the kinase and what are the unique/shared targets for each
activation pathway? Finally, what is the relative importance of
oxidized versus autophosphorylated CaMKII in normal and
diseased hearts? Answers to these questions will not only facilitate
the development of more comprehensive models but also will
provide critical information necessary to design novel cell-specific
therapies for regulating cardiac excitability.
It is important to note that CaMKII in the model detects a
subspace pool of Ca
2+ that reaches concentrations somewhere
between cytosolic and dyadic concentrations (peak concentration
10–20 mM). Previous modeling studies have shown that the
dynamic response of CaMKII may vary greatly between dyadic
and cytosolic pools based on variability in concentrations of Ca
2+
and CaM [27]. Consistent with previous studies [27], we found
that cytosolic Ca
2+ transients do not significantly activate CaMKII
activity at baseline or even in the presence of 1 mMH 2O2 (,1%
maximal activity, not shown). However 10 mMH 2O2 was able to
activate CaMKII (25% maximal), suggesting that a sufficiently
high level of oxidative stress may be able to activate even cytosolic
CaMKII. Clearly, local regulation of CaMKII in well-defined
subcellular domains is an exciting area for future research with
important implications for human disease. As we learn more about
CaM and CaMKII signaling in the vicinity of Na
+ channels, it will
be important to incorporate these data into the model.
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activation in regulating conduction in the infarct BZ. Conduction
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over a range of end diastolic membrane potentials (Vm,dia). [K
+]o is
increased incrementally from 5.4 mM to 13 mM to Vm,dia from
287 to 263 mV. Elimination of autophosphorylation-dependent
CaMKII activation has a small effect on conduction velocity
compared to elimination of oxidation-dependent activation.
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